TRAZODONE TABLETS
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract specifies the procurement of Trazodone Hydrochloride Tablets in 100 mg strength, packaged in bottles of 100 tablets, with a required shelf life of 24 months from the date of manufacture. At least 21 months must remain on the shelf at the time of delivery to the government, meaning no product can be delivered with less than 21 months of usable life remaining. All labeling and packaging must strictly comply with Medical Marking Standard No. 1A dated February 4, 2013, superseding all references to MIL-STD-129. The product is regulated by the FDA, and the contracting official must submit a referral through EBS to the product specialist prior to award, including bidder and manufacturer details such as name, part number, and item description. Packaging must be commercial-grade, sealed appropriately to prevent damage, and suitable for safe transport via common carrier at the lowest cost to the designated delivery point. The material must be marked and labeled in full accordance with the Medical Marking Standard, and if deemed non-hazardous per FED-STD-313, it must be packed in compliance with ASTM D3951, though DLA’s Master List of Technical and Quality Requirements takes precedence over any conflicting commercial standards. Palletization must follow DLA Packaging Requirements for Procurement, and shipment must be sent by the fastest traceable means, explicitly excluding parcel post. The delivery destination is Fort Bragg, North Carolina, with a required delivery window of 20 days from award and a firm required delivery date of August 7, 2026. The quantity ordered is three bottles, with no tolerance for variance in quantity. The NSN is 6505-01-137-0032, and the unit of issue is "BOTTLE." Approved manufacturers include Mead Johnson & Company, LLC, Teva Pharmaceuticals USA, Inc., and Apotex Corp., each with their respective NDC numbers. The contract identifies the procurement under solicitation number SPE2DP-26-T-4520, issued by the Department of Defense’s Medical Supply Chain Pharmaceutical FSA, with Alec Deichman listed as the primary point of contact. The contract includes specific federal and defense logistics identifiers, freight shipping details, and government-only tracking codes, reinforcing the item’s inclusion under controlled defense acquisition regulations. All packaging, labeling, and fulfillment must adhere to these exacting standards to
General Info
Agency
NAICS
Place of Performance
BLD A5474 PRATT ST, FORT BRAGG, NC, 28310, USSet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Response Deadline
Organization & Contact Information
Full Description
TRAZODONE HYDROCHLORIDE TABLETS<(>,<)>
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
100 MG, BOTTLE OF 100'S
U/I "BOTTLE"
SHALL HAVE A SHELF LIFE OF 24 MONTHS.
NOT LESS THAN 21 MONTHS SHALL HAVE ELAPSED FROM DATE OF MANUFACTURE TO
DATE OF DELIVERY TO THE GOVERNMENT.
.
LABELING AND MARKING MUST IN ACCORDANCE WITH MEDICAL MARKING STANDARD
NO. 1A DATED 4 FEBRUARY 2013.
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
SPE2DP-26-T-4520
SECTION B
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS016: Shelf-life requirement RS001 for a TYPE I (CODE M) item with a shelf life of 24 months (non-extendable) applies to this item.
MEAD JOHNSON & COMPANY, LLC 29398 P/N NDC00087-0776-41 TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC50111-0561-01 APOTEX CORP. 4PX51 P/N NDC60505-2654-01
TDP Rev A Gen 1 IAW REFERENCE REVISION NR DTD PART PIECE NUMBER:
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017754804 0001 BT 3.000
NSN/MATERIAL:6505011370032
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
BULK BREAK POINT:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
SPE2DP-26-T-4520
SECTION B
PR: 7017754804 PRLI: 0001 CONT’D
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
SHIP BY FASTEST TRACEABLE MEANS. DO NOT USE PARCEL POST.
FREIGHT SHIPPING ADDRESS:
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
MARKFOR
W50YF2
0051 MD CO MEDICAL LOGISTI
AWCF SSF
BLD A5474 PRATT ST
FORT BRAGG NC 28310
US
M/F: (TCN) W50YF262160132
RDD: 230
PROJ: TP 2
SUPP ADD: W9046W SIG: C
FOR GOVERNMENT USE ONLY: (IPD) 05
DIC: A0A DIST: V ADV: 2A FC: Z9
Need Ship Date:00/00/0000 Original Required Delivery Date:08/07/2026
SPE2DP-26-T-4520 NSN/Part Number: 6505-01-137-0032 Quantity: 3 BT Purchase Request: 7017754804QTY: 3 Delivery: 20 days ADO
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
